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Summary
 
Consistent with their role in host defense, mature dendritic cells (DCs) from central lymphoid
organs preferentially prime for T helper cell type 1 (Th1)-polarized immunity. However, the
“default” T helper response at mucosal surfaces demonstrates Th2 polarity, which is reflected in
the cytokine profiles of activated T cells from mucosal lymph nodes. This study on rat respira-
tory tract DCs (RTDCs) provides an explanation for this paradox. We demonstrate that freshly
isolated RTDCs are functionally immature as defined in vitro, being surface major histo-
compatibility complex (MHC) II
 
lo
 
, endocytosis
 
hi
 
, and mixed lymphocyte reaction
 
lo
 
, and these
cells produce mRNA encoding interleukin (IL)-10. After ovalbumin (OVA)-pulsing and
adoptive transfer, freshly isolated RTDCs preferentially stimulated Th2-dependent OVA-spe-
cific immunoglobulin (Ig)G
 
1
 
 responses, and antigen-stimulated splenocytes from recipient ani-
mals produced IL-4 in vitro. However, preculture with granulocyte/macrophage colony stim-
ulating factor increased their in vivo IgG priming capacity by 2–3 logs, inducing production of
both Th1- and Th2-dependent IgG subclasses and high levels of IFN-
 
g
 
 by antigen-stimulated
splenocytes. Associated phenotypic changes included upregulation of surface MHC II and B7
expression and IL-12 p35 mRNA, and downregulation of endocytosis, MHC II processing–
associated genes, and IL-10 mRNA expression. Full expression of IL-12 p40 required additional
signals, such as tumor necrosis factor 
 
a
 
 or CD40 ligand. These results suggest that the observed
Th2 polarity of the resting mucosal immune system may be an inherent property of the resi-
dent DC population, and furthermore that mobilization of Th1 immunity relies absolutely on
the provision of appropriate microenvironmental costimuli.
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M
 
ucosal surfaces such as those of the lung represent
sites of intense exposure to a wide variety of inert
and infectious agents and thus provide uniquely challenging
microenvironments for the maintenance of immunological
homeostasis. At such sites, the T cell system is required to
respond rapidly to infectious challenge via the initiation of
sterilizing immunity, while at the same time avoiding large
scale inflammatory responses to inert, nonreplicating anti-
gens. Disruption of this homeostasis, as in hyperreactivity
to inhaled allergens, is central in the pathogenesis of many
respiratory disorders, including rhinitis and asthma.
Within mucosal environments, APCs play a key regula-
tory role via sampling and presenting antigen in a form rec-
ognizable by the immune system. Among APC populations
present within the mucosae, dendritic cells (DCs)
 
1
 
 are
unique in being able to efficiently stimulate primary immu-
nity. Previous studies from our (1, 2) and other (3, 4) labo-
ratories have identified DCs as the principal resident APC
of the rat, mouse, and human lung and have shown that
these cells form a contiguous network throughout the air-
way epithelium (5), placing them in an ideal position to
sample and process inhaled antigens.
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cell; GAM-PE, PE-conju-
gated goat anti–mouse IgG; GKN, solution consisting of 11 mM 
 
d
 
-glu-
cose, 5.5 mM KCl, 137 mM NaCl, 25 mM Na
 
2
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4
 
, and 5.5 mM
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4
 
 
 
3
 
 2H
 
2
 
O; m
 
f
 
, macrophages; RTDC, respiratory tract DC;
RT-PCR, reverse transcriptase PCR.
  
2020
 
Functional Activity of Respiratory Tract Dendritic Cells
 
The ability to rapidly acquire large amounts of antigen
(6, 7), in conjunction with expression of high levels of
MHC and costimulatory molecules (8, 9), makes DCs po-
tent APCs both in vitro (10–12) and in vivo (13, 14).
However, it has been suggested that the functional activi-
ties of individual DCs are closely linked to their matura-
tional status, i.e., resident DCs in peripheral tissues are pro-
posed to be of the “immature” type and are specialized for
antigen uptake as opposed to activation of T cells, whereas
the reverse applies for mature DCs in secondary lymphoid
organs (15–17). This functional dichotomy provides a the-
oretical mechanism for avoidance of chronic T cell–medi-
ated tissue damage at sites (especially mucosal) of continu-
ous antigen exposure, i.e., transmission of activating signals
to the T cell system by DCs normally only occurs after their
migration to, and functional maturation within, central
lymphoid organs, especially the draining lymph nodes (18).
An important functional role for mature DCs is consid-
ered to be in the clearance of infectious agents (19) facili-
tated by the rapid induction of high-level IL-12 production
by these cells (20–22) and leading to upregulation of IFN-
 
g
 
production and Th1-mediated responses (23). The mucosal
surfaces of the gastrointestinal and respiratory tracts are the
sites of most frequent contact with pathogens, and the
dense and highly dynamic DC populations at these sites (5,
24–26) are believed to play key roles in orchestrating these
host-protective immune responses. However, the initial re-
sponse to inhaled soluble protein antigens is dominated by
Th2-dependent IgE production (27–29) and/or the pro-
duction of Th2 cytokines in the regional lymph nodes
draining the airway mucosa (29, 30), and a comparable Th2
“default” is operative at the level of the gastric mucosa (31–
33). Furthermore, T cells isolated from lymph nodes that
drain mucosal sites have been shown to predominantly
produce IL-4 upon activation in vitro (34). Given that DCs
are the principal APCs responsible for initiation of immune
reactivity to both infectious and inhaled/ingested agents,
the inherent Th1-promoting activity of DCs described
above is inconsistent with the observations that immune
responses at mucosal sites are essentially Th2 dominated.
To address this paradox, we have analyzed the functional
activity of RTDCs in the resting state and after exposure to
cytokines previously demonstrated to induce functional
maturation of DCs from other sources.
 
Materials and Methods
 
Animals.
 
Inbred PVG.RT7
 
b 
 
(RT1
 
c
 
RT7
 
b
 
), WAG (RT1
 
u
 
), or
BN (RT1
 
n
 
) strain rats were bred free of common rat pathogens
in-house at the Institute for Child Health Research and housed
under conventional conditions. 8-wk-old female animals were
generally used except in the case of lung donors, in which case
older (
 
.
 
13 wk) animals were used.
 
Media and Reagents.
 
The tissue culture medium used was
RPMI 1640 supplemented with 2 mM 
 
l
 
-glutamine, 5 
 
3 
 
10
 
-5
 
 M
2-ME, and antibiotics, as well as either 5% FCS (Trace Bio-
sciences, Melbourne, Australia) or 1% normal rat serum. Cell iso-
lation procedures were performed in ice-cold PBS supplemented
 
with 0.2% BSA (PBS/BSA) or a solution of 11 mM 
 
d
 
-glucose,
5.5 mM KCl, 137 mM NaCl, 25 mM Na
 
2
 
HPO
 
4
 
, and 5.5 mM
NaH
 
2
 
PO
 
4
 
 3 
 
2H
 
2
 
O (GKN) supplemented with 5% FCS (GKN/
FCS) or 0.2% BSA (GKN/BSA) as indicated. Mouse rGM-CSF
(Biosource International, Camarillo, CA) was used at a final con-
centration of 10 ng/ml. FITC-conjugated dextran (FITC-DX),
 
M
 
r
 
 5 
 
40 kD, was purchased from Molecular Probes (Eugene,
OR), and Collagenase A was from Boehringer Mannheim (Mann-
heim, Germany). AMV reverse transcriptase and Taq DNA poly-
merase were from Promega (Madison, WI).
 
mAbs and Cell-staining Reagents.
 
Mouse mAbs to rat CD4
(W3/25), CD8 (OX8), CD11b/c (OX42), CD45 (OX1),
RT1.A
 
c
 
 (OX27), RT1.B (OX6), Ig 
 
k 
 
chain (OX12), and human
C3b inactivator (OX21) were donated by Dr. Don Mason, MRC
Cellular Immunology Unit, University of Oxford, Oxford, UK;
WT.1 (LFA-1
 
a
 
) and 1A-29 (ICAM-1) were donated by Dr. M.
Miyasaka, Osaka University, Osaka, Japan; and 3H5 (CD80) and
24F (CD86) were donated by Dr. H. Yagita, Juntendo Univer-
sity, Tokyo, Japan. Conjugates of OX6 IgG with FITC (OX6-
FITC) or biotin (OX6b) were prepared in-house and in the case
of the OX6b were used in conjunction with streptavidin-PE (Se-
rotec, Kidlington, UK). A mouse CTLA4–human Ig Fc fusion
protein (CTLA4-Ig) cross reactive with rat B7 was provided by
Dr. M. Dallman, Imperial College, London, UK. Isotype controls
were used as TCS (OX21) or as IgG1-FITC or IgG1-PE conju-
gates (Dako, Denmark). Binding of mouse mAbs was detected
using a goat anti–mouse IgG-PE (GAM-PE) conjugate (Dako)
and CTLA4-Ig using a goat anti–human IgG-PE conjugate (Im-
munotech, Marseilles, France). Cell samples were analyzed for
surface fluorescence by flow cytometry using an Epics XL flow
cytometer (Coulter Corp., Miami, FL) with forward- and side-
angle light scatter gating combined with fluorescence channel
gating to collect a minimum of 5 
 
3 
 
10
 
3
 
 OX6
 
1
 
 events. Rabbit an-
tipan-cytokeratin antibody for immunostaining of epithelial cells
was obtained from Nycomed Amersham (Little Chalfont, Buck-
inghamshire, UK); immunoperoxidase staining of cytospin prepa-
rations of DCs was performed via standard methods.
 
Cell Preparations.
 
Collagenase A digests of perfused lung tis-
sue were obtained from 10–13-wk-old rats using a previously de-
scribed procedure (1). Digests of whole lung tissue were depleted
of endogenous macrophages (m
 
f
 
) by nylon wool elution in
GKN/FCS and washed in GKN/BSA, and residual contaminat-
ing B cells were removed by labeling with the OX12 mAb fol-
lowed by magnetic depletion using anti–mouse IgG-coated
MACS beads (Miltenyi Biotec, Bergisch Gladbach, Germany).
After this procedure, contaminating m
 
f
 
 were undetectable and B
cells were 
 
,
 
5%. The depleted cells were then washed and incu-
bated with GAM-PE to label residual OX12
 
1
 
 B cells, followed
by blocking with 10% normal mouse serum and incubation with
OX6-FITC to label MHC class II
 
1
 
 cells. OX6
 
1
 
OX12
 
2 
 
RTDCs
were then purified by dual-parameter cell sorting (Epics Elite;
Coulter Corp.) using chilled GKN plus 20% FCS as the collec-
tion medium. Splenic DCs were prepared by essentially the same
procedure using Collagenase A digests of rat spleen.
An initial series of experiments were performed using 88–94%
pure DC preparation containing up to 3% contaminating epithe-
lial cells as defined by cytokeratin staining. The study was subse-
quently replicated with DC preparations that were re-sorted to
achieve 98% purity, with identical results.
 
Analysis of Endocytosis by Flow Cytometry and Confocal Microscopy.
 
For quantitative analysis of RTDC endocytic activity, whole lung
digests were depleted of m
 
f
 
 and B cells as described above and
labeled with OX6-biotin/streptavidin-PE. 5 
 
3 
 
10
 
5
 
 cells were 
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then resuspended in RPMI/FCS containing 0.5 mg/ml FITC-DX
for 90 min either at 37
 
8
 
C or on ice (0
 
8
 
C). The reaction was
stopped by washing in ice-cold PBS/BSA and mean FL1 (FITC)
fluorescence intensity of OX6
 
1
 
 cells was determined by flow cy-
tometry. Results from these mixed-cell assays were further con-
firmed using purified RTDCs. For confocal microscopy analysis
of single-cell uptake, purified RTDCs were incubated with
FITC-DX as described above, washed, and then fixed in PBS
containing 1% paraformaldehyde. 10
 
5
 
 cells were then allowed to
settle onto glass coverslips and fluorescence distribution was ana-
lyzed by confocal laser microscopy (Bio-Rad Labs., Hercules,
CA). Results of single z-plane analyses are reported.
 
MLR.
 
Purified fresh or GM-CSF–exposed RTDCs were re-
suspended in RPMI/FCS and added at a final concentration of
1.25 
 
3 
 
10
 
4
 
 cells/well of round-bottomed 96-well microtiter
plates, then serially diluted twofold. Allogeneic responder T cells
were purified from WAG-strain cervical lymph nodes by nylon
wool elution and added at a final concentration of 1.25 
 
3 
 
10
 
5
 
cells/well. The cultures were then incubated for 72 h followed by
an 18-h pulse with 0.5 
 
m
 
Ci of [
 
3
 
H]thymidine. Results are ex-
pressed as mean CPM 
 
6 
 
SEM for triplicate wells.
 
In Vivo DC Transfer Protocol.
 
The adoptive transfer protocol
used was adapted from the protocol of De Becker et al. (35)
with minor modifications. Purified DCs were resuspended to 10
 
6
 
cells/ml in RPMI/FCS and pulsed at 37
 
8
 
C with 1 mg/ml
OVA (Sigma Chemical Co., St. Louis, MO) for 90 min for fresh
RTDCs or overnight in the presence of 10 ng/ml rGM-CSF for
RTDCs and spleen DCs. In some cases cells were pulsed with
OVA for 90 min and washed before culture in GM-CSF. The
cells were then washed in protein-free PBS and 10
 
5
 
 viable cells
were transferred intravenously into 8-wk-old female syngeneic
recipients. After 5 d the animals were challenged with 10 
 
m
 
g/ml
OVA in PBS intravenously and serum samples were prepared 15 d
after OVA challenge. In cases where ex vivo spleen cell cultures
were required, the cells were pulsed with OVA before transfer in
the presence of 1% autologous normal rat serum instead of FCS
to avoid presentation of bovine proteins during the in vitro cul-
tures. Control animals received 1 ml of PBS intravenously on day
0 and 10 
 
m
 
g OVA intravenously on day 5.
 
OVA-specific IgG Subclass Analysis.
 
OVA-specific IgG sub-
classes were assayed by ELISA using microtiter plates coated
overnight at 4
 
8
 
C with 10 
 
m
 
g/ml OVA in PBS. The plates were
blocked with 1% BSA for 60 min at room temperature and then
incubated with serum samples serially diluted in PBS for 2 h at
room temperature. After washing, bound IgG subclasses were de-
tected using biotin-conjugated rabbit anti–rat IgG1, IgG2a, and
IgG2b (Amersham Pharmacia Biotech, Piscataway, NJ) incubated
for 2 h at room temperature followed by an anti–biotin–horse-
radish peroxidase conjugate (Boehringer Mannheim, Mannheim,
Germany) for 60 min at room temperature then horseradish per-
oxidase substrate (K-Blue
 
Ô
 
; Neogen, Lexington, KY). OD at 450
nm was assessed after 20 min. The concentration of each IgG
subclass was determined by comparison with standard curves run
in parallel, generated by coating plates with dilutions of purified
rat IgG1, IgG2a, and IgG2b (Amersham Pharmacia Biotech) fol-
lowed by the detection system described above, and the results
were expressed as micrograms per milliliter of IgG. Serum IgE ti-
ters were assayed by the PCA method as previously described
(36).
 
Spleen Cell Proliferation and Cytokine Protein Assays.
 
Single cell
suspensions (including RBCs) of whole spleens from DC transfer
recipients were prepared 15 d after OVA challenge and incubated
in 96-well microtiter plates at 1.25 
 
3 
 
10
 
5
 
 cells/well in 0.2-ml
volumes at 37
 
8
 
C in RPMI/FCS containing 50 
 
m
 
g/ml OVA. Af-
ter 72 h, cell proliferation was assessed by [
 
3
 
H]thymidine incorpo-
ration added for 18 h and results were expressed as mean CPM 
 
6
 
SEM of triplicate wells. At the 72 h time point, culture superna-
tants were taken for analysis of rat IFN-
 
g
 
 protein by ELISA (29)
and IL-4 by B cell bioassay using upregulation of MHC class II as
previously described (37).
 
Semiquantitative Reverse Transcriptase PCR.
 
Total RNA was
prepared from 10
 
5
 
 purified RTDCs by RNAzol B extraction
(Biogenesis, Poole, UK) according to the manufacturer’s instruc-
tions and mRNA was reverse transcribed to cDNA. Semiquanti-
tative analysis of mRNA levels was then performed by PCR us-
ing cDNA serially diluted in reaction buffer from neat to 1:25 to
ensure that PCR products were being analyzed under nonsaturat-
ing conditions. Amplification of 
 
b
 
-actin mRNA was to ensure
equivalent cDNA levels between samples; any experiments show-
ing disparities in 
 
b
 
-actin levels were discarded. The sequences of
PCR primer pairs used are listed in Table 1, whereas primers spe-
cific for mouse IL-12 p35 that cross-reacted with rat (expected
product size 308 bp) were purchased from Biosource Interna-
tional. To determine mRNA/
 
b
 
-actin ratios, PCR products were
 
Table 1.
 
Rat PCR Primer Sequences
 
Target mRNA
Primer sequence (5
 
9
 
–3
 
9
 
)
Product size Sense Antisense
 
bp
 
RT1.B cag tca cag aag gcg ttt atg gat cgc agg cct tga atg atg 279
RT1.DMa aac ata ggg ctc tcc gag atg aaa cag acc agc gtg 281
RT1.DMb gtc caa gta gcc caa acc acc acg cag gtg tag atg 233
Ii tga aga atg tta cca agt atg g tgg tca ata ctt tag gtg gag 252
Calnexin tgt att gat gtc tcg ggc act cac act tag ggt tgg 725
IL-10 cac tgc tat gtt gcc tgc tc ttc atg gcc ttg tag aca cc 463
IL-12 p40 tgg agt cat agg ctc tgg a gat gaa gaa gct ggt gct g 484
 
b
 
-actin atg cca tcc tgc gtc tgg acc tgg agc att tgc ggt gca cga tgg agg g 607 
2022
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separated on 1.5% agarose gels and ratios of mRNA/
 
b
 
-actin band
densities at 1:5 dilutions of cDNA determined by densitometry.
 
Statistics.
 
Statistical comparisons of mean values were per-
formed using the nonparametric Mann-Whitney test for unpaired
samples with two-tailed
 
 P 
 
value using the InStat software package
(GraphPad Software, San Diego, CA).
 
Results
 
Surface Phenotype Freshly Isolated and GM-CSF–matured
RTDCs.
 
Surface marker expression on fresh and GM-
CSF–matured RTDCs was analyzed using m
 
f
 
- and B cell–
depleted lung digests colabeled with mAbs to a range of rat
lymphoid and myeloid cell surface antigens in conjunction
with the anti–rat MHC class II mAb OX6. Approximately
10% of cells within freshly isolated lung digests were putative
RTDCs as determined by positive labeling for OX6 and fail-
ure to express m
 
f
 
 or B cell markers (data not shown) and, as
depicted in Table 2, a significant proportion expressed low
levels of MHC class I and class II, CD4 and CD11a, and a
small percentage expressed ICAM-1 and CD45, whereas
the majority were negative for CD8, CD11b/c, and B7.
However, after overnight exposure to 10 ng/ml GM-CSF,
dramatic increases in expression of MHC class I and class II
and B7 were observed, with moderate increases in CD45
and CD11a and CD11b/c, and decreases in CD4 and
CD54 (Table 2).
 
GM-CSF Upregulates the Antigen-presenting Activity of
RTDCs.
 
The phenotypic changes after exposure of freshly
isolated RTDCs to GM-CSF described above, particularly
the dramatic increases in MHC and B7 molecule expression,
suggested that freshly isolated RTDCs may be functionally
“immature” as APCs and that the observed maturational in-
crease in surface expression of costimulatory molecules after
exposure to GM-CSF should invoke a more potent APC
activity. To investigate this, RTDCs were sorted to high
 
purity on the basis of MHC class II expression as described in
Materials and Methods and analyzed either as freshly isolated
cells or after overnight exposure to GM-CSF. As shown in
Fig. 1 
 
A
 
, exposure to 10 ng/ml GM-CSF resulted in an
 
z
 
10-fold increase in the level of surface MHC class II
expression when compared with freshly isolated cells. In ad-
dition, this was associated with a marked increase in MLR-
stimulating activity (Fig. 1 
 
B
 
), suggesting that RTDCs un-
dergo functional maturation after exposure to GM-CSF.
This was further confirmed by analysis of surface B7 expres-
sion, which revealed no expression of CD80 but low levels
of CD86 on fresh RTDCs, the levels of which were both
dramatically increased after exposure to GM-CSF, particu-
larly on the MHC class II
 
hi
 
 subset (Fig. 2, 
 
A
 
 and 
 
B
 
).
 
Table 2.
 
Surface Phenotype of Fresh and GM-CSF–exposed RTDCs
 
*
 
Marker mAb
Fresh Plus GM-CSF
Percentage frequencies MFI Percentage frequencies MFI
CD4 W3/25 29.7 4.5 2.9 2.7
CD8 OX8 2.0 3.6 2.5 6.0
CD11a WT.1 13.9 3.7 19.4 7.2
CD11b/c OX42 3.3 3.1 10.8 6.8
CD45 OX1 5.9 3.3 8.0 3.0
CD54 1A-29 8.9 6.3 4.1 9.9
CD80/86 CTLA-4 Ig 0.8 2.2 54.8 38.6
MHC class I OX27 18.7 5.4 62.0 10.2
MHC class II OX6 100 11.5 100 55.1
*Lung digests were depleted of mf and B cells as described in Materials and Methods and labeled with the indicated mAbs and GAM-PE (or
CTLA-4 Ig and GAH-PE) followed by OX6-FITC. Percentage frequencies and mean fluorescence intensities (MFI) are shown for 5 3 103 OX61
gated RTDCs using positive analysis regions set on isotype-matched controls.
Figure 1. Surface MHC class II expression and MLR-stimulating ac-
tivity of fresh and GM-CSF–exposed RTDCs. (A) Purified RTDCs were
labeled with OX6-FITC either as fresh cells (thin line) or after culture in
GM-CSF (thick line), or with the isotype control IgG1-FITC (dotted line),
and surface fluorescence analyzed by flow cytometry. (B) Serial dilutions
of freshly purified (open circles) or GM-CSF–exposed (filled circles) RTDCs
were added as stimulators to a primary allogeneic MLR in the presence of
105 purified WAG-strain T cells per well of 96-well microtiter plates. Cell
proliferation (CPM) was assessed after a total of 96 h including an 18-h
[3H]TdR pulse. Mean 6 SEM of triplicate wells of one representative of
three experiments is shown.2023 Stumbles et al.
Modulation of the Endocytic Activity of RTDCs by GM-CSF.
Recent studies of human peripheral blood–derived DCs have
established that immature DCs are capable of high levels of
receptor-mediated and fluid phase endocytosis, the levels of
which are rapidly downregulated upon in vitro maturation
(38). These changes are thought to occur in vivo  when
peripheral tissue DCs, specialized for antigen acquisition,
mature and migrate to draining lymph nodes, where their
primary role becomes T cell activation. To analyze the
endocytic activity of RTDCs, the uptake of FITC-DX by
freshly isolated and GM-CSF matured RTDCs was assessed.
Freshly isolated RTDCs were actively endocytic, as indicated
by their ability to acquire high levels of FITC-DX at 378C
(Fig. 3, A and B). The majority of this endocytic activity was
confined to an MHC class IIint subset, which represented
z30% of the total RTDC population (Fig. 3 B, a), although
a distinct MHC class IIhi population that was negative for
endocytosis was also present. This latter population may
represent a more mature subset of cells that have downregu-
lated endocytic activity (see below). Time course analysis of
the uptake of FITC-DX by this subset showed detectable en-
docytic activity after 5 min with a peak at 60 min (Fig. 3 C).
To further confirm the endocytic ability of freshly iso-
lated RTDCs, internalization of FITC-DX was examined
by confocal microscopy. At lower magnifications a range of
labeling intensities could be observed, with the more
strongly endocytic cells appearing to incorporate the label
into intracellular vesicles (Fig. 3 D, top), which displayed a
peripheral cytoplasmic distribution (Fig. 3 D, bottom). This
pattern of vesicle distribution within the cytoplasm was sim-
ilar to that described for human monocyte-derived DCs (7).
As already noted, studies of DCs isolated from human
peripheral blood have described a maturational process
whereby endocytic activity is downregulated concomi-
tantly with an upregulation of cell-surface costimulatory
molecule expression and T cell–stimulating activity. To de-
termine whether the maturational increases in MHC class
II and B7 expression and MLR-stimulating activity described
above for RTDCs (Figs. 1 and 2) were also associated with
a downregulation of endocytic activity, FITC-DX incorpo-
ration by freshly isolated and GM-CSF–matured RTDCs
were compared. As shown in Fig. 4, exposure of fresh
RTDCs to GM-CSF down-regulated both the percentage
of endocytically active cells (Fig. 4 A) and the levels of
FITC-DX uptake (Fig. 4 B).
Taken together, these results demonstrate that freshly
isolated RTDCs are actively endocytic and that this en-
docytic activity is subject to downregulation after in vitro
Figure 2. CD80 and CD86 expression by fresh and GM-CSF–exposed RTDCs. Fresh (A) or GM-CSF–exposed (B) RTDC were colabeled with the
OX21 (IgG1), 3H5 (CD80), or 24F (CD86) mAbs plus GAM-PE followed by OX6-FITC, and surface fluorescence analyzed by flow cytometry. Quad-
rant markers were set for IgG1-FITC/IgG1 plus GAM-PE negative control cells.2024 Functional Activity of Respiratory Tract Dendritic Cells
maturation that is associated with an increase in surface
MHC class II and B7 expression and in vitro APC activity.
Thus, under steady-state conditions, freshly isolated RT-
DCs appear to be of the immature functional phenotype
described for DCs isolated from other sites.
GM-CSF-induced Upregulation of Surface MHC Class II
Expression Is Not Associated with Increased mRNA Biosynthesis.
Recently it has been demonstrated that DC maturation
leads to stabilization and persistence of MHC class II–pep-
tide complexes on the cell surface, the majority of which
are rapidly mobilized from the intracellular pool with only
transient increases in de novo protein biosynthesis (39, 40).
To determine whether the observed increase in surface ex-
pression of MHC class II after exposure of RTDCs to GM-
CSF was due to increased biosynthesis of MHC class II
protein, changes in expression of mRNA encoding a num-
ber of molecules involved in MHC class II biosynthesis and
peptide loading were analyzed by reverse transcriptase
(RT)-PCR. As shown in Fig. 5, exposure to GM-CSF in-
duced no detectable increase in the levels of expression of
mRNA transcripts for RT1.B or the assembly protein caln-
exin. Furthermore, decreases were observed in the expres-
sion of mRNA encoding molecules involved in peptide
loading of assembled MHC class II molecules, including in-
variant chain (Ii) and RT1.DMa and DMb (Fig. 5). These
results suggest that the observed increase in surface MHC
class II expression on RTDC induced by GM-CSF was not
due to increased protein biosynthesis, and are consistent
with previous observations indicating that this increased
surface protein is mobilized from an intracellular pool. In
addition, the decreases in Ii and RT1.DM mRNA expres-
sion suggest that mature RTDCs may have a reduced anti-
gen processing/MHC class II peptide loading capacity as
described for mature DCs isolated from other sites (38).
Fresh RTDCs Prime for Th2-dependent Antigen-specific IgG
Subclass Production. Having established the functional ac-
tivity of freshly isolated and GM-CSF–matured RTDCs in
vitro, we then analyzed the functional properties of these
populations of RTDCs in vivo, particularly with respect to
their ability to prime for antigen-specific T and B cell re-
sponses. Recent reports have demonstrated that DCs
pulsed with antigen in vitro act as potent adjuvants when
administered in vivo (41), with studies in the mouse show-
ing that splenic DCs are effective at inducing immune re-
Figure 3. Endocytic activity of fresh RTDC. Freshly purified RTDC
were incubated at 08C (A) or 378C (B) for 90 min in the presence of 0.5
mg/ml FITC-DX then labeled with the OX6 mAb plus GAM-PE and
fluorescence levels analyzed by flow cytometry after trypan blue quench-
ing. (C) Time-course of FITC-DX uptake by fresh RTDCs. RTDCs
were incubated with FITC-DX as described above and the percentage of
endocytically positive cells falling within an arbitrary gating region (B, a)
determined by flow cytometry. Percentage endocytic values were cal-
culated by subtracting values obtained at 08C from those obtained at
378C. One representative out of three experiments is shown. (D) Confo-
cal microscopic analysis of FITC-DX uptake by fresh RTDCs.
Figure 4. Inhibition of the endocytic activity of fresh RTDCs by GM-
CSF. Fresh or GM-CSF–exposed RTDCs were incubated for 90 min at
378C with 0.5 mg/ml FITC-DX. Percentage endocytic (A) or D MFI (B)
values were then calculated from 08C and 378C percentage and mean
fluorescence values using gating as described in Fig. 3 B. Mean values 6
SEM for three experiments are shown.
Figure 5. Changes in expression of mRNA encoding components of
the MHC class II biosynthesis/processing pathway in fresh or GM-CSF–
exposed RTDC. (A) cDNA was prepared from RTDCs either as fresh
cells or after overnight culture in GM-CSF and used either undiluted (un-
dil.) or diluted 1:5 or 1:25 in a PCR reaction using primers specific for
the indicated MHC class II biosynthesis and antigen processing-associated
proteins as described in Materials and Methods. (B) MHC class II compo-
nent:b-actin mRNA band density ratios (1:5 cDNA dilution) for fresh
(solid bars) and GM-CSF–exposed (white bars) RTDCs. One representa-
tive out of two experiments is shown. RT1.B, rat MHC class II; Calnx,
calnexin; Ii, invariant chain; DMa/DMb, RT1.DMa/b.2025 Stumbles et al.
sponses that involved predominantly Th1-dependent IgG
antibodies, accompanied by comparatively low levels of
Th2-dependent IgG subclasses (35). We therefore exam-
ined the ability of fresh and GM-CSF–matured, OVA-
pulsed RTDCs to induce OVA-specific IgG responses in
vivo and analyzed the Th-dependent nature of this re-
sponse in terms of IgG subclass production. Freshly isolated
or GM-CSF–exposed RTDCs were incubated at 378C
with 1 mg/ml soluble OVA for 90 min or overnight as de-
scribed in Materials and Methods, and 105 cells were trans-
ferred intravenously to syngeneic recipients. After 5 d, the
animals were challenged intravenously with 10 mg/ml
OVA in PBS and OVA-specific IgG subclass production
was analyzed 15 d later. As shown in Fig. 6 A, animals that
received freshly isolated, OVA-pulsed RTDCs produced
levels of OVA-specific IgG1 (6.6 6 1.3 mg/ml) that were
significantly greater than those receiving unpulsed RTDCs
or PBS (2.2 6 0.5 and 1.8 6 0.2 mg/ml; P 5 0.01 and
0.005, respectively). In contrast, fresh RTDCs failed to
prime for IgG2b production and did not induce signifi-
cantly raised levels of IgG2a (Fig. 6 A) or IgE (data not
shown) when compared with controls.
In the rat, IgG1 has been shown to be a Th2-dependent
IgG subclass, whereas IgG2b production is indicative of a
Th1 response (42, 43). Less direct evidence also suggests
that rat IgG2a is Th2 dependent (44, 45). Thus, the above
data suggests that freshly isolated RTDCs, through induc-
tion of IgG1 but not IgG2b, appeared to prime preferen-
tially for a Th2-dependent antibody response in vivo. Fur-
ther evidence supporting the Th2-polarizing potential of
fresh “resting” RTDCs is shown in Fig. 6 B, where animals
repeatedly challenged with OVA-pulsed fresh RTDCs on
three occasions at weekly intervals showed increasing levels
of IgG1 and IgG2a and not IgG2b, indicating that restric-
tion of the antigen-specific restimulation signal to fresh
RTDCs maintains the Th2 polarization of the ensuing an-
tibody response as it matures.
GM-CSF-exposed RTDC Prime for both Th1- and Th2-
dependent Antigen-specific IgG Subclass Production. In contrast
to the above results obtained with fresh RTDCs, exposure
to GM-CSF before transfer dramatically upregulated the in
vivo priming activity of RTDCs, with dramatic increases
in the production of IgG1 (307 6 92 mg/ml), IgG2a (894 6
167 mg/ml), and IgG2b (147 6 22 mg/ml) when com-
pared with freshly isolated cells indicating increased prim-
ing for both Th1- and Th2-dependent responses (Fig. 7).
To further support this, analysis of serum IgE demonstrated
an increase in IgE titers in recipients of GM-CSF–matured
RTDCs, reaching titers equivalent to those obtained after
immunization with OVA in the Th2-skewing adjuvant
aluminium hydroxide (data not shown). Thus, mature RT-
DCs now more closely resembled the responses induced by
rat splenic-derived DCs, which in this study induced
equivalently high levels of all three subclasses, and which,
furthermore, are consistent with results reported for mouse
splenic-derived DCs (35).
Induction of OVA-specific T Cell Responses by Fresh and
GM-CSF–exposed RTDCs. To investigate the in vivo T
cell priming activity of RTDC preparations, OVA-specific
proliferation and IFN-g production were examined in cul-
tures of spleen cells isolated from adoptive transfer recipi-
ents 15 d after the intravenous OVA challenge. As shown
in Table 3, freshly isolated OVA-pulsed RTDCs failed to
prime for detectable ex vivo OVA-specific spleen cell pro-
liferative responses and induced production of low levels of
IL-4, (but not IFN-g) consistent with the low-level, Th2-
skewed IgG production induced by these cells (Fig. 6 A).
In contrast, exposure to GM-CSF significantly upregu-
lated the ability of OVA-pulsed RTDCs to prime in vivo
Figure 6. In vivo priming for OVA-
specific IgG production by freshly iso-
lated RTDCs. Freshly sorted RTDCs
were pulsed with 1 mg/ml OVA for 90
min at 378C and washed, and 105 cells in
1 ml PBS were transferred intravenously
into syngeneic recipients. (A) Animals
received a single dose of OVA-pulsed
RTDCs on day 0 and were then chal-
lenged with 10 mg/ml OVA on day 5
and bled on day 20. Control animals re-
ceived either 105 unpulsed RTDCs or
1 ml PBS on day 0. *P 5 0.01 and **P 5
0.005 compared with OVA-pulsed RT-
DCs. (B) Animals received one dose of RTDCs weekly for 3 wk and were bled 1 wk after final RTDC transfer. *P 5 0.005; **P 5 0.008; and ***P 5 0.01
compared with animals receiving 13 RTDCs. In all cases serum OVA-specific IgG1, 2a, and 2b levels were then assessed by ELISA as described in
Materials and Methods. Mean 6 SEM of five animals in each group are shown and these experiments have been repeated on several subsequent occasions.
Figure 7. In vivo priming for
OVA-specific IgG production
by GM-CSF–exposed RTDCs.
Sorted RTDCs or splenic DCs
(SpDC) were incubated over-
night at 378C with 1 mg/ml
OVA and 10 ng/ml GM-CSF,
then transferred intravenously to
syngeneic recipients, and serum
IgG1, 2a, and 2b levels were de-
termined as described in Fig. 6
A. Identical results for RTDCs
were obtained using 90-min
OVA-pulsing before overnight culture in GM-CSF (data not shown).
Results are expressed as mean 6 SEM for 9 (RTDC) or 10 (SpDC) ani-
mals. *P , 0.0001 compared with fresh RTDCs.2026 Functional Activity of Respiratory Tract Dendritic Cells
for OVA-specific spleen cell responses, inducing a signifi-
cant degree of ex vivo OVA-specific spleen cell prolifera-
tion and high level IFN-g production (Table 3), consistent
with the increased ability of these cells to prime for Th1-
dependent IgG2b production (Fig. 7). The inability to de-
tect IL-4 in these cultures, despite the coproduction of
Th2-dependent IgG subclasses in these animals, may reflect
cytokine consumption in these rapidly proliferating cul-
tures or shutdown (spontaneous or IFN-g–mediated) of
IL-4–secreting cells at this time point (Table 3). OVA-
pulsed splenic DCs also induced levels of OVA-specific
spleen cell proliferation and IFN-g production that were of
a similar order to that induced by GM-CSF–exposed RT-
DCs (Table 3), suggesting overall that these two DC types
showed similar T cell priming activity in vivo.
RT-PCR Analysis of IL-10 and IL-12 mRNA Produc-
tion by Fresh and GM-CSF–exposed RTDCs. To examine
whether the functional differences observed between
RTDC preparations could be associated with changes in
production of immunoregulatory cytokines, semiquantita-
tive RT-PCR analysis for mRNA encoding IL-10 and IL-
12 was performed on cDNA isolated from highly purified
fresh or GM-CSF–exposed RTDCs. IL-12, a hetero-
dimeric protein consisting of a p35 and p40 chain (46), is
one of the major cytokines regulating induction of Th1-
mediated responses (23) and has been shown to be pro-
duced in large quantities by mature DCs (21, 47). IL-10 has
been shown to be produced by several cell types (48), in-
cluding DCs (49), and is known to be a key regulator of
Th2-mediated immune reactions.
Analysis of cDNA from freshly isolated RTDCs clearly
demonstrated the presence of mRNA encoding IL-10,
which were downregulated approximately two- to fivefold
after exposure to GM-CSF (Fig. 8, A and B). For IL-12,
freshly isolated RTDCs expressed low levels of mRNA en-
coding the p35 chain which were markedly increased after
overnight exposure to GM-CSF (Fig. 8 A). Analysis of IL-
12p35/b-actin band density ratios indicated that this repre-
sented a fourfold increase in the level of mRNA expression
(Fig. 8 B). In contrast, mRNA encoding the p40 chain of
IL-12 appeared to be highly expressed in freshly isolated
cells and generally dropped 30–50% after exposure to GM-
CSF (Fig. 8, A and B).
These findings suggested that high level expression of
IL-12 by RTDCs requires additional maturation stimuli
and several laboratories have reported a role for TNF-a
and CD40 ligand (CD40L) in this context (50, 51),
prompting the experiments shown in Fig. 8 B. These indi-
cate that IL-12 p40 mRNA expression is upregulated in the
presence of both TNF-a, and CD40L, but requires 48 h of
exposure; IL-12 p35 expression in the same cells main-
tained the high levels observed in GM-CSF–stimulated
cultures at 24 h (data not shown). IL-12 p40 mRNA pro-
duction was not maintained in 48-h cultures containing
GM-CSF alone (Fig. 8 B).
Discussion
Recent studies have established that resident tissue DCs
function as “sentinel” cells, being specialized for the acqui-
sition of antigens ranging from soluble protein through to
Table 3. Cell Proliferation, IFN-g, and IL-4 Production in Ex Vivo Spleen Cell Cultures of DC Adoptive Transfer Recipients*
Type of DC transferred No. of animals Proliferation IFN-g IL-4
CPM 3 1023 U/ml U/ml
Fresh RTDCs 5 3.0 6 0.8 0.1 1.6 6 0.39
RTDCs 1 GM-CSF 7 36.3 6 2.2 10.2 6 2.5 0
Spleen DCs 9 69.4 6 4.1 14.8 6 3.3 nt
Control** 8 3.8 6 0.6 0.1 nt
*Each animal intravenously received 105 OVA-pulsed DCs in 1 ml PBS on day 0 and 10 mg OVA on day 5. After 15 d, single cell suspensions of
whole spleen were stimulated in vitro with 50 mg/ml OVA and analyzed for cell proliferation by [3H]thymidine incorporation, IFN-g by ELISA,
and IL-4 by bioassay after 72 h of culture. Results are expressed as mean 6 SEM. nt, not tested.
**Controls intravenously received 1 ml PBS on day 0 and 10 mg OVA on day 5.
Figure 8. Expression of IL-10 and IL-12 by fresh and GM-CSF–
exposed RTDCs. (A) cDNA prepared from freshly isolated or GM-CSF–
exposed RTDCs was used either undiluted (undil.) or diluted 1:5 and
1:25 in PCR reactions for rat IL-10 and IL-12p35 and p40 mRNA as de-
scribed in Materials and Methods. (B) IL-10/IL-12:b-actin mRNA band
density ratios (1:5 cDNA dilution) for fresh RTDCs and RTDCs exposed
to GM-CSF alone for 24 or 48 h or GM-CSF plus TNF or CD40L for
48 h only. Mean values 6 SEM for three experiments are shown for fresh
and GM-CSF–exposed RTDCs, and representative results of a single ex-
periment are shown for GM-CSF plus TNF or CD40L.2027 Stumbles et al.
viral particles (15, 52). These and subsequent in vitro stud-
ies on the growth of DCs from precursors (53) suggest a
complex life history for these cells, involving the progres-
sive transition through functionally distinct phases as they
mature. Thus, relatively “immature” DCs from cultures of
bone marrow–derived precursors grown in GM-CSF 1
IL-4 have been suggested to be equivalent to those in peri-
pheral tissues, being specialized for antigen uptake but inef-
fective as activators of T cells. In contrast, the more mature
DCs grown in GM-CSF 1 TNF-a and CD40L are hypo-
thesized to be equivalent to those residing as interdigitating
cells in secondary lymphoid organs, displaying low capacity
for antigen uptake but potent T cell activating function (38).
However, it is not known precisely how applicable this
model is to DC populations in vivo, particularly to those at
mucosal surfaces such as RTDCs, which display steady-state
turnover rates up to 10 times faster than more studied DC
populations such as epidermal Langerhans cells (24).
This study therefore sought to characterize in detail the
functional phenotype of RTDCs in resting tissue and to
determine the degree to which their function(s) can be
modulated via stimuli previously identified as promoters of
DC maturation. The overall aim of this study was to eluci-
date the role of RTDCs in Th1/Th2 regulation of immune
responses to antigens impacting on the airway mucosa, and
accordingly a key element of these experiments involved
analysis of the in vivo T cell priming properties of RTDCs
after adoptive transfer.
The salient findings from these experiments are as fol-
lows. First, it is clear that a major subset of resident RTDCs
express surface phenotypic features comparable to “imma-
ture” DCs grown in vitro from blood- and bone marrow–
derived precursors, particularly expression of low-moderate
levels of MHC class I and II and also CD80/86, coupled
with high endocytic activity and poor capacity to stimulate
MLR responses. However, significant heterogeneity exists
with respect to intensity of expression of several markers, in
particular MHC class I and II and CD4. Ultra high level
MHC class II expression was limited to a minor subset of
freshly isolated RTDCs and these cells were nonendocytic
(Fig. 3), suggesting possible maturation in situ (see below).
We plan future follow-up studies on subsets defined by in-
tensity of expression of these markers.
It is additionally clear that culture with GM-CSF elicits a
series of changes associated with functional upregulation,
notably increased expression of MHC class I and II and
CD80/86 together with a loss of endocytic activity, a de-
crease in expression of a series of genes encoding molecules
involved in antigen processing, and a concomitant increase
in MLR-stimulatory activity. CD4 expression was also lost
(Table 2) and the significance of this observation will be
explored in later studies.
Thus, respiratory mucosal surfaces are endowed with a res-
ident population of DCs that are highly specialized for uptake
and processing of antigen, and capable of rapid maturation
into potent APCs upon receipt of appropriate cytokine sig-
nals. The heterogeneity observed, particularly with respect to
MHC class II expression and levels of endocytic activity, sug-
gests that the population overall represents a developmental
continuum that is skewed heavily (at least in the steady state)
towards the “immature” functional phenotype. It will be of
interest to determine whether this activity spectrum changes
with acute and chronic stimulation, given recent findings in-
dicating the uniquely dynamic features of the RTDC popula-
tions under conditions of local stress (5, 25, 54).
Although well characterized in vitro, the functional ac-
tivity of DC in vivo, particularly in terms of their ability to
activate Th1- or Th2-mediated T cell responses, still re-
mains unclear to a large extent. The primary role of these
cells is thought to involve protection against infectious
agents (19, 55) through strong promotion of Th1-depen-
dent immunity, primarily via production of high levels of
IL-12 (21, 50, 56). However, as noted above, studies focus-
sing on mucosal surfaces such as the lung and gut clearly in-
dicate that the baseline response to inert antigens at these
sites displays a Th2 bias. Accordingly, a key aim of this study
was to determine the relationship between the ex vivo phe-
notype of RTDCs and their in vivo functions, in the context
of Th1/2 switch regulation. The experiments reported in
Fig. 6 A demonstrate that freshly isolated RTDCs are able to
prime T helper cells in adoptive recipients, but the priming
is relatively weak and restricted to Th2-dependent IgG1.
The experiments of Fig. 6 B provide further evidence of
Th2 bias on the part of these RTDCs, via the demonstration
that three successive challenges with antigen-pulsed DCs
progressively expands the Th2-dependent IgG subclass com-
ponent of these responses (IgG1 and IgG2a), with minimal
effects on Th1-dependent IgG2b production.
In contrast, GM-CSF–matured RTDCs display a 1–2
log increase in overall priming capacity, which includes a
major component of Th1-dependent IgG2b, and this pat-
tern was identical to that seen with splenic DCs (Fig. 7),
and is consistent with earlier reports on mouse splenic DCs
(14, 35). Thus, it appears that resident RTDCs under
steady-state conditions are programmed for induction of
Th2-biased responses, and require endogenous activation/
maturation signals in order to develop capacity to stimulate
Th1 immunity. A possible explanation for these findings
was provided by RT-PCR analysis of cytokine production,
which demonstrated expression of mRNA encoding IL-10
in fresh RTDCs (Fig. 8). IL-10 is known to have potent
immune-modulating effects (57, 58) and acts to preferen-
tially inhibit Th1 priming. Thus, IL-10 inhibits IL-12 pro-
duction by DCs (47) and pretreatment of DCs with IL-10
has been shown to suppress their ability to stimulate Th1
responses both in vitro and in vivo (59–62). In addition,
treatment of DCs with PGE2, a Th2-promoting inflamma-
tory mediator, downregulates IL-12 and upregulates IL-10
production and the in vitro Th2-stimulating capacity of
these cells (49). Consistent with these observations, fresh
RTDCs appeared to produce mRNA for both subunits of
IL-12, but the available data suggests that assembly of the
functional heterodimer in these cells may be severely lim-
ited by the restricted levels of p35 subunit available (Fig. 8).
Recent evidence also suggests that IL-10 acts posttransla-
tionally to inhibit surface expression of MHC class II (63),2028 Functional Activity of Respiratory Tract Dendritic Cells
and thus IL-10 production by fresh RTDCs may contrib-
ute to the low steady-state expression of this marker on the
majority of these cells. This may serve to limit the magni-
tude of the antigen signal delivered to T cells to the (low)
dose range that preferentially promotes Th2-dominated re-
sponses (64). Moreover, IL-10 has been demonstrated to
suppress CD80 expression (65), and its production by fresh
RTDCs may thus contribute towards selective expression on
these cells of CD86 (Fig. 2). It has been suggested that co-
stimulation through CD86 preferentially activates Th2 im-
munity (66), although this issue remains controversial (67).
IL-10 at relatively high concentrations has also been
demonstrated to exert a generalized inhibitory effect on T
cell proliferation (48), and it is accordingly possible that IL-
10 production by fresh RTDCs may act to limit the overall
size of the primary immune responses that they induce.
Thus, autocrine production of IL-10 by RTDCs may
contribute towards restriction of the T cell priming activity
of these cells to the promotion of (initially) low level Th2-
biased responses, via a number of mechanisms. Consistent
with this hypothesis, exposure of RTDC to GM-CSF
markedly upregulates both Th2 and Th1 priming capacity,
and this is accompanied by concomitant downregulation of
IL-10 mRNA production and increased production of IL-
12 p35 mRNA (Fig. 8). Although the production of IL-12
p40 mRNA remained low, the observation that GM-CSF–
exposed RTDCs behaved in vivo in a functionally similar
fashion to rat (Fig. 7) and mouse (35) splenic DCs, being
strong inducers of both Th1- and Th2-mediated responses,
indicated that functionally active IL-12 is likely to have
been produced in vivo. This suggests that the levels of IL-
12p35 and IL-12p40 produced by GM-CSF–treated RT-
DCs are sufficient to yield biologically significant amounts
of IL-12 heterodimer, and/or that stimulatory factors in ad-
dition to GM-CSF (for example CD40L; reference 50) be-
come available to the RTDCs after adoptive transfer.
Collectively, these findings provide a plausible explana-
tion for the constitutive Th2 bias operative in mucosal im-
mune responses to inert protein antigens, which is amena-
ble to further testing. In particular, it will be important to
formally demonstrate the production of bioactive IL-10 and
IL-12 protein by RTDCs, and this issue will be addressed in
future experiments. The underlying mechanism(s) described
above may also play a significant role in the progressive devi-
ation of immune responses to airborne protein antigens from
initial Th2 to eventual Th1 polarity, a phenomenon that has
been described in detail in both animal model experiments
and in humans undergoing chronic exposure to inhaled anti-
gen (68). We speculate that other classes of antigen that in-
duce local inflammation in the airway mucosa, particularly
microbial antigens, would elicit responses with a much large
Th1 component as a result of the effects of inflammation-
associated cytokines on RTDCs.
Additionally, the above results suggest new avenues for
research into the aetiology and pathogenesis of respiratory
allergy. Two distinct phases are now recognized in these
diseases in humans. The first involves a failure of immune
deviation mechanisms that normally bias immune responses
against inhaled protein antigens towards Th1, resulting in
the development of potentially pathogenic Th2-polarized
memory and the active production of specific IgE antibody
(69). The second phase, which occurs in only a subset of
subjects who develop Th2 memory against these inhaled
antigens, involves chronic airways inflammation character-
ized by the presence of large numbers of activated T cells
(70), which infers the presence in the airway mucosa of
functionally mature APCs. It is of interest to note in this
context that local airway intraepithelial production of high
levels of GM-CSF is a hallmark of atopic asthma (71). It is
also relevant to note recent studies that suggest that periph-
eral tissue DC populations comprise two distinct myeloid
lineages, one of which is characterized by high endocytic
activity/IL-10 production/capacity to induce naive B cell
switching, and the second being specialized for T cell acti-
vation (72, 73). The balance between these two subpopula-
tions in the airway mucosa in the steady state and during
inflammation may be an important determinant of local
immune responder phenotype. The principal focus of on-
going studies in this model will accordingly be upon
RTDC heterogeneity.
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